Bristol-Myers Squibb BMYB34 Balance Sheet

Income Statement

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	100.36B	98.2B	96.82B	94.28B	93.49B	91.26B	95.16B	99.03B
Total Current Assets	30.19B	26.8B	27.27B	27.09B	28.07B	27.63B	31.77B	28.67B
Cash and Equivalents	10.75B	7.73B	9.12B	9B	8.37B	7.51B	11.46B	9.33B
Total Non-Current Assets	76.14B	77.44B	75.8B	73.47B	71.77B	70.11B	70.04B	77.11B
Total Liabilities	67.7B	65.46B	65.7B	62.4B	61.46B	62.2B	65.67B	82.48B
Total Current Liabilities	20.92B	18.93B	21.89B	19.09B	20.15B	23.46B	22.26B	25.82B
Total Non-Current Liabilities	83.89B	83.5B	78.87B	78.39B	75.97B	70.88B	80.07B	106.15B
Common Equity	292M	292M	292M	292M	292M	292M	292M	292M
Retained Earnings	24.22B	24.68B	25.5B	26.57B	27.45B	28.22B	28.77B	15.64B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	33.71B	33.55B	34.99B	129.94B	118.48B	109.31B	96.82B	95.16B
Total Current Assets	13.7B	14.85B	17.16B	29.35B	30.19B	33.26B	27.27B	31.77B
Cash and Equivalents	4.24B	5.42B	6.91B	11.87B	14.55B	13.98B	9.12B	11.46B
Total Non-Current Assets	16.35B	11.85B	14.13B	51.7B	37.88B	36.01B	31.12B	29.49B
Total Liabilities	17.36B	21.7B	20.86B	78.25B	80.6B	73.31B	65.7B	65.67B
Total Current Liabilities	8.84B	9.56B	10.65B	18.3B	19.08B	21.87B	21.89B	22.26B
Total Non-Current Liabilities	14.24B	19.12B	15.85B	103.33B	109.86B	91.05B	78.87B	80.07B
Total Equity	16.35B	11.85B	14.13B	51.7B	37.88B	36.01B	31.12B	29.49B
Common Equity	221M	221M	221M	292M	292M	292M	292M	292M
Retained Earnings	33.51B	31.16B	34.07B	34.47B	21.28B	23.82B	25.5B	28.77B